Glaukos Corp. (GKOS)

117.01 +0.83 (+0.71%) USD  |  NYSE  |  Dec 24, 12:21
More

Glaukos SG&A Expense (TTM): 306.05M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GKOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Boston Scientific Corp. 6.666B
Perspective Therapeutics, Inc. 31.53M
Xtant Medical Holdings, Inc. 74.03M
VolitionRX Ltd. 13.97M
Catheter Precision, Inc. 12.42M